首批科创成长层企业启动申购

Group 1 - The core viewpoint of the news is the launch of the first batch of companies under the newly established Sci-Tech Growth Layer, with Wuhan Heyuan Biotechnology Co., Ltd. being the first to initiate its subscription [1][2] - Heyuan Biotechnology is a biopharmaceutical company that has multiple drugs in the research and development phase and is issuing 89.4514 million shares [1] - Other companies, Xi'an Yicai and Bibete, will also start their subscription this week, with Xi'an Yicai being a leading domestic 12-inch semiconductor silicon wafer company and Bibete focusing on major diseases such as tumors and autoimmune diseases [1] Group 2 - The establishment of the Sci-Tech Growth Layer was announced by the China Securities Regulatory Commission in June, aimed at supporting technology-driven companies that have significant breakthroughs and broad commercial prospects but are currently unprofitable [2] - A total of 32 existing unprofitable companies have automatically entered the Sci-Tech Growth Layer, and newly registered unprofitable companies will also enter upon listing [2] - Companies in the Sci-Tech Growth Layer will have a special identifier "U" in their stock abbreviation to enhance risk disclosure [2]